The Metabolism of Mexiletine in Relation to the Debrisoquine/Sparteine- Type Polymorphism of Drug Oxidation.

British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/j.1365-2125.1991.tb03931.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Debrisoquine Oxidation Polymorphism in Patients With Rheumatoid Arthritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1994English

Involvement of CYP1A2 in Mexiletine Metabolism

British Journal of Clinical Pharmacology
Pharmacology
1998English

Debrisoquine Hydroxylase Gene Polymorphism in Familial Parkinson's Disease.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1994English

Relation of Collagen Metabolism to Calcium Metabolism in the Bone.

Acta Chemica Scandinavica
1968English

Debrisoquine Metabolism and Genetic Predisposition to Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

Impaired Oxidation of Debrisoquine in Patients With Perhexiline Neuropathy.

BMJ
1982English

The Oxidative Metabolism of Sparteine in the Cuna Amerindians of Panama: Absence of Evidence for Deficient Metabolizers

Clinical Pharmacology and Therapeutics
Pharmacology
1988English

Genetic Polymorphism of Drug Metabolism Enzymes (GSTM1, GSTT1 and GSTP1) in the Healthy Malian Population

Molecular Biology Reports
MedicineGeneticsMolecular Biology
2019English

Amphetamine-Positive Urine Drug Screens in the Setting of Mexiletine Use: A Case Series

Journal of Heart and Lung Transplantation
CardiologyTransplantationCardiovascular MedicinePulmonaryRespiratory MedicineSurgery
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy